News

US FDA approves generic versions of blood thinner Plavix

18-05-2012

Coinciding with the loss of patent protection on Sanofi (Euronext: SAN) and Bristol-Myers Squibb's (NYSE:…

Cardio-vascularClopidogrelDr Reddy's LaboratoriesGenericsMylan LaboratoriesNorth AmericaPlavixRegulation

Indian, Israeli and US drugmakers leap into US market with generic Seroquel

29-03-2012

Less than a week after a US District Court for the District of Columbia issued an opinion and order in…

AstraZenecaDr Reddy's LaboratoriesGenericsLupinMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaQuetiapine FumarateSeroquelSun Pharmaceutical IndustriesTeva Pharmaceutical Industries

Dr Reddy’s launches generic Aricept, Effexor and Femara in USA; FDA clears Mylan ANDA

08-06-2011

Indian generics drug major Dr Reddy’s Laboratories (NYSE: RDY) yesterday announced that it has launched…

AriceptDr Reddy's LaboratoriesEffexorFemaraGenericsMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaOncologyRegulation

Four drugmakers gain US appro for generic Cipro

14-06-2004

June 10 saw the approval of four generic versions of Bayer's antibiotic Cipro (ciprofloxacin) by the…

AspirinBayerBayerCiproCiprofloxacinDr Reddy's LaboratoriesMylan LaboratoriesTeva Pharmaceutical Industries

COMPANY SPOTLIGHT

Menarini

Back to top